HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming Chen Selected Research

ganoderic acid D

1/2022Sporoderm-Broken Spores of Ganoderma lucidum Sensitizes Ovarian Cancer to Cisplatin by ROS/ERK Signaling and Attenuates Chemotherapy-Related Toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming Chen Research Topics

Disease

264Neoplasms (Cancer)
07/2022 - 02/2002
56Prostatic Neoplasms (Prostate Cancer)
03/2022 - 01/2003
54Inflammation (Inflammations)
12/2022 - 08/2004
49Neoplasm Metastasis (Metastasis)
01/2022 - 08/2004
45Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 02/2002
34Infections
12/2022 - 01/2002
24Breast Neoplasms (Breast Cancer)
07/2022 - 01/2007
24Lung Neoplasms (Lung Cancer)
06/2022 - 03/2009
23Carcinogenesis
01/2022 - 03/2005
20Renal Cell Carcinoma (Grawitz Tumor)
07/2022 - 10/2010
20Hypoxia (Hypoxemia)
01/2022 - 10/2002
19Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2022 - 10/2008
19Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2013
17Nasopharyngeal Carcinoma
01/2022 - 10/2004
14Hypertension (High Blood Pressure)
08/2022 - 10/2004
14Asthma (Bronchial Asthma)
01/2021 - 08/2006
14Carcinoma (Carcinomatosis)
01/2021 - 05/2004
13Cardiovascular Diseases (Cardiovascular Disease)
05/2022 - 12/2010
12Fibrosis (Cirrhosis)
08/2022 - 12/2007
12Pneumonia (Pneumonitis)
06/2022 - 10/2008
12Shock
04/2022 - 12/2003
12Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 07/2017
12Alzheimer Disease (Alzheimer's Disease)
11/2021 - 12/2002
11Myocardial Infarction
08/2022 - 01/2009
11Dehydration (Water Stress)
01/2022 - 02/2007
10Stomach Neoplasms (Stomach Cancer)
01/2022 - 04/2011
10Wounds and Injuries (Trauma)
01/2021 - 05/2003
10Thrombosis (Thrombus)
12/2017 - 06/2003
9Sepsis (Septicemia)
12/2022 - 01/2012
9Obesity
05/2022 - 12/2004
9Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 08/2015
9Lymphatic Metastasis
04/2021 - 09/2004
9Melanoma (Melanoma, Malignant)
01/2021 - 05/2009
9Airway Remodeling
10/2020 - 10/2008
9Cataract (Cataracts)
01/2019 - 01/2007
8Tuberculosis (Tuberculoses)
04/2022 - 09/2011
8COVID-19
03/2022 - 01/2020
8Hemorrhage
02/2022 - 09/2011
8Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 12/2014
8Ischemia
10/2021 - 01/2007
8Edema (Dropsy)
10/2020 - 02/2006
8Hyperplasia
01/2019 - 11/2009
7Pain (Aches)
11/2022 - 02/2003
7Lung Injury
01/2022 - 10/2008
7Bacterial Infections (Bacterial Infection)
01/2021 - 02/2010
7Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 11/2012
7Chronic Hepatitis B
01/2021 - 05/2006

Drug/Important Bio-Agent (IBA)

78Proteins (Proteins, Gene)FDA Link
06/2022 - 12/2002
54Biomarkers (Surrogate Marker)IBA
08/2022 - 09/2004
41MicroRNAs (MicroRNA)IBA
06/2022 - 05/2013
39Pharmaceutical PreparationsIBA
07/2022 - 05/2002
26Messenger RNA (mRNA)IBA
01/2021 - 11/2005
25Biological ProductsIBA
07/2022 - 03/2006
22Long Noncoding RNAIBA
01/2022 - 12/2016
19RNA (Ribonucleic Acid)IBA
01/2022 - 05/2014
18Therapeutic UsesIBA
07/2022 - 09/2009
17Cisplatin (Platino)FDA LinkGeneric
01/2022 - 03/2002
15CytokinesIBA
01/2022 - 08/2006
14Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2007
14Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2009
13DNA (Deoxyribonucleic Acid)IBA
06/2022 - 03/2007
13LipidsIBA
01/2022 - 07/2015
12Small Interfering RNA (siRNA)IBA
03/2022 - 11/2005
12Indicators and Reagents (Reagents)IBA
01/2021 - 04/2010
11AndrogensIBA
12/2019 - 01/2011
10Circular RNAIBA
01/2022 - 01/2019
10Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 04/2008
9ElementsIBA
01/2022 - 02/2007
9Genetic Markers (Genetic Marker)IBA
08/2017 - 12/2010
8CateninsIBA
08/2022 - 01/2013
8Insulin (Novolin)FDA Link
01/2022 - 10/2007
8EnzymesIBA
01/2022 - 01/2013
8PlatinumIBA
01/2022 - 11/2015
8Amyloid (Amyloid Fibrils)IBA
11/2021 - 12/2002
8AntigensIBA
01/2021 - 09/2011
8CollagenIBA
01/2021 - 01/2011
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2020 - 08/2005
8AntioxidantsIBA
11/2020 - 05/2003
8Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2020 - 04/2010
7Hormones (Hormone)IBA
07/2022 - 01/2010
7AntibodiesIBA
07/2022 - 09/2011
7Immune Checkpoint InhibitorsIBA
06/2022 - 01/2019
7Tyrosine Kinase InhibitorsIBA
05/2022 - 10/2018
7Interleukin-6 (Interleukin 6)IBA
04/2022 - 05/2007
7Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 06/2003
7ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2012

Therapy/Procedure

98Therapeutics
07/2022 - 12/2002
62Radiotherapy
01/2022 - 02/2002
42Drug Therapy (Chemotherapy)
03/2022 - 12/2002
26Chemoradiotherapy
01/2022 - 10/2006
16Castration
03/2022 - 08/2012
13Aftercare (After-Treatment)
04/2022 - 09/2010
12Immunotherapy
06/2022 - 01/2014
12Nephrectomy
01/2022 - 10/2010
9Ligation
01/2022 - 01/2009
8Length of Stay
04/2022 - 10/2015
8Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2021 - 01/2007
7Precision Medicine
01/2022 - 01/2017
7Cystectomy
01/2022 - 07/2010
7Prostatectomy (Retropubic Prostatectomy)
01/2021 - 10/2015